The incidence of infusion reactions associated with monoclonal antibody drugs targeting the epidermal growth factor receptor in metastatic colorectal cancer patients: A systematic literature review and meta‐analysis of patient and study characteristics

BACKGROUND: Systemic cancer therapies may induce infusion reactions (IRs) or hypersensitivities. Metastatic colorectal cancer (mCRC) patients treated with anti‐EGFR therapies, including cetuximab and panitumumab, may be subject to these reactions. We conducted a meta‐analysis to estimate the IR inci...

Descripción completa

Detalles Bibliográficos
Autores principales: Bylsma, Lauren C., Dean, Rebecca, Lowe, Kimberly, Sangaré, Laura, Alexander, Dominik D., Fryzek, Jon P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Cancer Prevention
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745824/
https://www.ncbi.nlm.nih.gov/pubmed/31376243
http://dx.doi.org/10.1002/cam4.2413

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745824/
https://www.ncbi.nlm.nih.gov/pubmed/31376243
http://dx.doi.org/10.1002/cam4.2413

Ejemplares similares